Mesenchymal cell-derived exosomes to treat neurological disorders
US11129852B2 · kind B2 · utility
0Cited by
23References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 2017 |
| Grant date | Sep 28, 2021 |
| Priority date | — |
| Expiry date | Jun 16, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a neurological disease (such as autism) in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of microparticles derived from mesenchymal stem cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.